Povezanost između dobi i pola pacijenta sa rezultatima indirektnog imunofluorescentnog testa kod pacijenata sa buloznim dermatozama
Sažetak
Background/Aim: Autoimmune bullous diseases are characterised by the production of autoantibodies to epidermal or subepidermal adhesive proteins. The aim of this study was to determine the relationship between age and sex of patients with the results of indirect immunofluorescence test in patients with newly diagnosed bullous dermatoses.
Methods: The investigation presents a retrospective study of newly diagnosed patients with autoimmune bullous diseases at the Clinic for Skin and Venereal Diseases of the University Clinical Centre in Banja Luka in the period 2016-2021. In addition to demographic data, the results of an indirect immunofluorescence test in two titres (≥ 1:10 and ≥ 1:100) were analysed.
Results: In this study, almost the same number of patients with pemphigus (45.2 %) and pemphigoid (54.8 %) was found. There were more women than men in the total sample (p = 0.049). The average age of subjects with pemphigoid was higher than that of patients with pemphigus (p = 0.001). 48.2 % of patients with pemphigus and 51.8 % of patients with pemphigoid had a positive indirect immunofluorescence test. A positive test for epidermal intercellular substance in both sexes at a titre ≥ 1:100 is higher than a titre ≥ 1:10 (p = 0.029). Patients with autoantibody titres ≥ 1:100 to desmoglein-1 were statistically significantly older than patients with titres ≥ 1:10 (p = 0.047).
Conclusion: Number of patients with pemphigus and pemphigoid were similar, with no difference in sex distribution between the two groups of patients, but patients with pemphigoid were older than patients with pemphigus. The difference between high and low autoantibody titres in both sexes was found only in the group of pemphigus on epidermal intercellular substance and desmoglein-1.
Reference
Di Lernia V, Casanova DM, Goldust M, Ricci C. Pemphigus vulgaris and bullous pemphigoid: update on diagnosis and treatment. Dermatol Pract Concept 2020;10(3):e2020050. doi: 10.5826/dpc.1003a50.
Kridin K, Schmidt E. Epidemiology of pemphigus. JID Innov 2021;1(1):100004. doi:10.1016/j.xjidi.2021.100004.
Alpsoy E, Akman-Karakas A, Uzun S. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid. Arch Dermatol Res 2015;307(4):291-8.
Ishii K, Yoshida K, Stanley JR, Yamagami J, Amagai M, Ishiko A. Pemphigus vulgaris and foliaceus IgG autoantibodies directly block heterophilic transinteraction between desmoglein and desmocollin. J Invest Dermatol 2020;140(10):1919-7.
Popescu IA, Statescu l, Vata D, Porumb-Andrese E, Patrascu AL, Grajdeanu IA, et al. Pemphigus vulgaris - approach and management. Exp Ther Med 2019;18(6):5056-4.
Hammers CM, Stanley JR. Mechanisms of disease: pemphigus and bullous pemphigoid. Annu Rev Pathol 2016;11:175-22.
Ahmed AR, Anwar S, Reche PA. Molecular basis for global incidence of pemphigoid diseases and differences in phenotypes. Front Immunol 2022;13:807173. doi: 10.3389/fimmu.2022.807173.
Arbache ST, Nogueira TG, Delgado L, Miyamoto D, Aoki V. Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience. An Bras Dermatol 2014;89(6):885-9.
Kutlubay Z, Sevim Keçici A, Çelik U, Mat MC. A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow-up. Turk J Med Sci 2021;51(1):124-9.
Alpsoy E, Akman-Karakas A, Uzun S. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid. Arch Dermatol Res 2015;307(4):291-8.
Milinković MV, Janković S, Medenica L, Nikolić M, Reljić V. Incidence of autoimmune bullous diseases in Serbia: a 20-year retrospective study. J. Dtsch Dermatol Ges 2016;14:995–1005.
Schmidt E, Kasperkiewicz M, Joly P. Pemphigus. Lancet. 2019;394:882–94.
De D, Khullar G, Handa S, Saikia UN, Radotra BD, Saikia B, et al. Clinical, demographic and immunopathological spectrum of subepidermal autoimmune bullous diseases at a tertiary center: A 1-year audit. Indian J Dermatol Venereol Leprol 2016;82(3):358. doi: 10.4103/0378-6323.175928.
Kridin K, Bergman R. The usefulness of indirect immunofluorescence in pemphigus and the natural history of patients with initial false-positive results: a retrospective cohort study. Front Med (Lausanne) 2018;5:266. doi: 10.3389/fmed.2018.00266.
Askin O, Ozkoca D, Kutlubay Z, Mat MC. A retrospective analysis of pemphigus vulgaris patients: Demographics, diagnosis, co-morbid diseases and treatment modalities used. North Clin Istanb 2020;7(6):597-602.
Hashimoto T, Teye K, Hashimoto K, Wozniak K, Ueo D, Fujiwara S, et al. Clinical and immunological study of 30 cases with both IgG and IgA anti-keratinocyte cell surface autoantibodies toward the definition of intercellular IgG/IgA dermatosis. Front Immunol 2018 May 7;9:994. doi: 10.3389/fimmu.2018.00994.
Delavarian Z, Layegh P, Pakfetrat A, Zarghi N, Khorashadizadeh M, Ghazi A. Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: correlation with disease severity. J Clin Exp Dent 2020;12(5):e440-e445.
Muhammed N, Korgaonkar S, Pradhan V, Khopkar US. A cross-sectional study to correlate disease severity in bullous pemphigoid patients with serum levels of autoantibodies against BP180 and BP230. Indian Dermatol Online J 2021;12(5):696-700.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).